CircNDUFB2 Inhibits Non-small Cell Lung Cancer Progression Via Destabilizing IGF2BPs and Activating Anti-tumor Immunity
Overview
Authors
Affiliations
Circular RNAs (circRNA) are a class of covalently closed single-stranded RNAs that have been implicated in cancer progression. Here we identify circNDUFB2 to be downregulated in non-small cell lung cancer (NSCLC) tissues, and to negatively correlate with NSCLC malignant features. Elevated circNDUFB2 inhibits growth and metastasis of NSCLC cells. Mechanistically, circNDUFB2 functions as a scaffold to enhance the interaction between TRIM25 and IGF2BPs, a positive regulator of tumor progression and metastasis. This TRIM25/circNDUFB2/IGF2BPs ternary complex facilitates ubiquitination and degradation of IGF2BPs, with this effect enhanced by N-methyladenosine (mA) modification of circNDUFB2. Moreover, circNDUFB2 is also recognized by RIG-I to activate RIG-I-MAVS signaling cascades and recruit immune cells into the tumor microenvironment (TME). Our data thus provide evidences that circNDUFB2 participates in the degradation of IGF2BPs and activation of anti-tumor immunity during NSCLC progression via the modulation of both protein ubiquitination and degradation, as well as cellular immune responses.
circZNF707 promoted glycolysis and tumor progression through miR-668-3p-PFKM axis in NSCLC.
Chen W, Fang S, Wu X, Fang T, Chen Z, Su W Eur J Med Res. 2025; 30(1):141.
PMID: 40016838 PMC: 11866724. DOI: 10.1186/s40001-025-02359-z.
circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC.
Chen W, Zhao W, Wu X, Fang T, Chen Z, Chen Z Cancer Med. 2025; 14(5):e70729.
PMID: 40013670 PMC: 11866311. DOI: 10.1002/cam4.70729.
Fang Z, Wu Z, Yu C, Xie Q, Zeng L, Chen R Mol Cancer. 2025; 24(1):56.
PMID: 40001070 PMC: 11863466. DOI: 10.1186/s12943-025-02262-5.
Xu X, Zhao W, Peng D, Sun Y, Tantai J, Zhao G Sci Rep. 2025; 15(1):5681.
PMID: 39956818 PMC: 11830784. DOI: 10.1038/s41598-025-87874-z.
Jiang S, Ou L, Wang Y, Su K, Chen Z, He L Int J Nanomedicine. 2025; 20:1597-1613.
PMID: 39931528 PMC: 11807777. DOI: 10.2147/IJN.S502400.